We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TPCO
2326
DELISTED
Tribune Publishing Company Common Stock
TPCO
| $422K | ﹤0.01% |
30,318
+758
| +3% | +$10.4K |
|
|
LGTY
2327
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $421K | ﹤0.01% |
40,970
+916
| +2% | +$9.48K |
|
|
CHFN
2328
DELISTED
Charter Financial Corp
CHFN
| $420K | ﹤0.01% |
21,356
+637
| +3% | +$11.5K |
|
2329
Geospace Technologies
GEOS
$93.5M
| $419K | ﹤0.01% |
25,813
+7,027
| +37% | +$133K |
|
|
ARNA
2330
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $419K | ﹤0.01% |
28,696
+1,079
| +4% | +$16K |
|
2331
Alpha and Omega Semiconductor
AOSL
$967M
| $418K | ﹤0.01% |
24,336
+1,239
| +5% | +$24.6K |
|
2332
PTC Therapeutics
PTCT
$5.67B
| $416K | ﹤0.01% |
42,293
+1,173
| +3% | +$14.2K |
|
2333
Acushnet Holdings
GOLF
$5.98B
| $415K | ﹤0.01% |
23,999
+12,899
| +116% | +$234K |
|
2334
Novavax
NVAX
$1.2B
| $414K | ﹤0.01% |
16,178
+562
| +4% | +$15.5K |
|
2335
CNB Financial Corp
CCNE
$1.04B
| $413K | ﹤0.01% |
17,286
+647
| +4% | +$16.1K |
|
|
CARB
2336
DELISTED
Carbonite Inc
CARB
| $413K | ﹤0.01% |
20,353
+833
| +4% | +$15.6K |
|
|
VWTR
2337
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
| $412K | ﹤0.01% |
29,438
+780
| +3% | +$11.1K |
|
2338
Greif Class B
GEF.B
$4.12B
| $411K | ﹤0.01% |
6,296
+212
| +3% | +$14.3K |
|
2339
KRONOS Worldwide
KRO
$691M
| $410K | ﹤0.01% |
24,958
+1,737
| +7% | +$24.2K |
|
2340
Mistras Group
MG
$487M
| $410K | ﹤0.01% |
19,156
+636
| +3% | +$14.4K |
|
2341
CRA International
CRAI
$1.18B
| $409K | ﹤0.01% |
11,577
+302
| +3% | +$10.6K |
|
|
GLBL
2342
DELISTED
TerraForm Global, Inc. Class A Common Stock
GLBL
| $409K | ﹤0.01% |
85,203
+5,005
| +6% | +$22.6K |
|
2343
Sierra Bancorp
BSRR
$529M
| $407K | ﹤0.01% |
14,821
+449
| +3% | +$12.2K |
|
2344
Orion Group Holdings
ORN
$403M
| $407K | ﹤0.01% |
54,487
+14,397
| +36% | +$136K |
|
|
TGH
2345
DELISTED
Textainer Group Holdings limited
TGH
| $407K | ﹤0.01% |
26,569
+356
| +1% | +$4.85K |
|
|
MB
2346
DELISTED
MINDBODY, Inc. Class A Common Stock
MB
| $406K | ﹤0.01% |
14,808
+437
| +3% | +$11.2K |
|
2347
PC Connection
CNXN
$2.12B
| $404K | ﹤0.01% |
13,569
+529
| +4% | +$14.6K |
|
2348
Geron
GERN
$795M
| $403K | ﹤0.01% |
177,575
+7,076
| +4% | +$15.1K |
|
|
BHR
2349
Braemar Hotels & Resorts
BHR
$156M
| $402K | ﹤0.01% |
38,238
+3,458
| +10% | +$43K |
|
2350
Evolent Health
EVH
$337M
| $402K | ﹤0.01% |
18,033
+845
| +5% | +$16.2K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.